Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-15

Clinical Trial Update: Fenfluramine and Cognition [Phase 4]

View source ↗

Summary

Phase 4 trial update examining fenfluramine effects on cognition has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fenfluramine (fenfluramine)

Snippet

Sponsor: University of Oxford | Conditions: Cognitive Function | Phase 4 | Status: COMPLETED